Clinical Trial Update: Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists [NA]

View source ↗

Summary

A clinical trial update aimed at identifying predictive factors of response to PD-1/PD-L1 inhibitors across multiple cancers, including melanoma, non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: UNICANCER | Conditions: Melanoma, Non Small Cell Lung Cancer | NA | Status: ACTIVE_NOT_RECRUITING